Related Experiment Video
Updated: Mar 29, 2026
08:43
Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
Published on: July 21, 2015
26.4K
Should Postanoxic Status Epilepticus Be Treated Agressively? Yes!
1Department of Clinical Neurosciences, Division of Neurology, Lund University, Lund, Sweden.
Summary
Cardiac arrest survivors face brain injury risks. Postanoxic status epilepticus does not guarantee poor prognosis and warrants active treatment for potential good outcomes in intensive care.
Area of Science:
- Neurology
- Critical Care Medicine
- Cardiology
Background:
- Cardiac arrest (CA) is a critical event with high mortality.
- Hypoxic-ischemic brain injury (HIBI) is a primary concern for CA survivors.
- Withdrawal of life-sustaining therapy is common due to presumed severe brain injury.
Purpose of the Study:
- To evaluate the prognostic significance of postanoxic status epilepticus (PSE) in cardiac arrest survivors.
- To advocate for evidence-based, multimodal prognostic assessment.
- To guide treatment strategies for patients with PSE.
Main Methods:
- Review of existing literature on prognostication after cardiac arrest.
- Analysis of factors influencing neurological outcomes in HIBI.
- Discussion of treatment protocols for postanoxic status epilepticus.
Main Results:
- Postanoxic status epilepticus is not a definitive criterion for poor neurological prognosis.
- Good neurological outcomes are possible in patients with PSE.
- Active treatment, including intensive care with antiepileptic and sedative agents, can suppress seizures.
Conclusions:
- Prognostic assessment in resuscitated cardiac arrest patients must be evidence-based and multimodal.
- PSE should not preclude aggressive management aiming for recovery.
- Active, prolonged intensive care is recommended for patients with PSE in the absence of clear poor prognostic indicators.
More Related Videos
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
18.3K
08:47Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
Published on: November 8, 2018
12.2K
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
01:20Antiepileptic Drugs: Potassium Channel Activators
956
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
956
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
01:13Seizures: Classification
2.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
01:30Electroconvulsive Therapy
2.0K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.0K
01:08Antiepileptic Drugs: Sodium Channel Blockers
2.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K